On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

A UCL study found that lamotrigine is as effective as mexiletine for treating non-dystrophic myotonia, a rare muscle disorder ...

Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

Septerna (SEPN), which is developing a treatment for hypoparathyroidism, has filed for a proposed $100M initial public ...

Rapamycin could counteract the harmful effects of Sodium Valproate, a common epilepsy medication, on fetal spinal cord development.

It took GLP-1 medications like Ozempic just seven years to surpass insulin as the the second most common treatment for type 2 ...

Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C.

Using patient-derived tumor organoids, researchers have identified which therapies may be most effective for individual sarcoma patients.

A task force commissioned by The Dalles and Wasco County officials have determined awards for drug treatment organizations ...

Lilly will add the center to a site in Lebanon, Indiana, where it is already spending about $9 billion to improve ...